• 7-Jul-2020 CYC 1H2020 Business Update CYC 1H2020 Business Update
• 5-Jun-2020 Notice of Annual General Meeting/Proxy Form Notice of Annual General Meeting/Proxy Form
• 29-May-2020 Technegas Approved in Russia - Clarification Technegas Approved in Russia - Clarification
• 27-May-2020 USFDA Approval to File Received for Technegas USFDA Approval to File Received for Technegas
• 26-May-2020 Technegas Approved in Russia Technegas Approved in Russia
• 21-May-2020 Final share buy-back notice - Appendix 3F Final share buy-back notice - Appendix 3F
• 6-May-2020 Form 484 cancellation of Long Term Incentive Plan shares Form 484 cancellation of Long Term Incentive Plan shares
• 5-May-2020 Appendix 2A Appendix 2A
• 14-Apr-2020 USFDA Grants Cyclopharm USD$2.9m Application Fee Waiver USFDA Grants Cyclopharm USD$2.9m Application Fee Waiver
• 31-Mar-2020 CYC Appendix 4G CYC Appendix 4G
• 31-Mar-2020 Annual Report to shareholders Annual Report to shareholders
• 30-Mar-2020 Cyclopharm Lodges NDA for Technegas with the USFDA Cyclopharm Lodges NDA for Technegas with the USFDA

Click here for archives